We are live on ! Find out more
TLSA icon

Tiziana Life Sciences
TLSA

11 hedge funds and large institutions have $10M invested in Tiziana Life Sciences in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

134,296% more capital inflows, than outflows

Capital inflows: $954K | Capital outflows: $710

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

38% more funds holding

Funds holding: 8 → 11 (+3)

0.53% more ownership

Funds ownership: 3.11% → 3.65% (+0.53%)

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$705K
2
Capital Asset Advisory Services
Capital Asset Advisory Services
Michigan
+$111K
3
Morgan Stanley
Morgan Stanley
New York
+$57.3K
4
HighTower Advisors
HighTower Advisors
Illinois
+$45.8K
5
Hoover Financial Advisors
Hoover Financial Advisors
Pennsylvania
+$20.9K

Top Sellers

Rank Fund Capital Flow
1
HighPoint Advisor Group
HighPoint Advisor Group
Illinois
-$710

TLSA Hedge Fund Activity: Q2 2020 in Review

11 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q2 2020, worth a combined $10M — up 178% from $3.6M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TLSA positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $705K. The largest seller was HighPoint Advisor Group, cutting an estimated $710.

  • 11 institutional investors held Tiziana Life Sciences (TLSA) as of Q2 2020, up from 8 in Q1 2020.
  • Funds reported $10M of Tiziana Life Sciences stock for Q2 2020, up 178% quarter-over-quarter.
  • 4 funds opened new Tiziana Life Sciences positions in Q2 2020 and 1 closed out, a net change of +3 holders.
  • The largest Tiziana Life Sciences buyer in Q2 2020 was Renaissance Technologies, an estimated $705K added.
  • The largest Tiziana Life Sciences seller in Q2 2020 was HighPoint Advisor Group, an estimated $710 sold.

Based on aggregated 13F filings for Q2 2020.